Vegetos

References

Ahmad B, Gamallat Y, Khan MF, Din SR, Israr M et al (2021) Natural polyphyllins (I, II, D, VI, VII) reverses cancer through apoptosis, autophagy, mitophagy, inflammation, and necroptosis. Onco Targets Ther 14:1821–1841


Ahn J, Kim H, Yang KM (2020) ω-Hydroxyundec-9-enoic acid induction of breast cancer cells apoptosis through generation of mitochondrial ROS and phosphorylation of AMPK. Arch Pharmacal Res 43(7):735–743


Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK et al (2021) Autophagy in healthy aging and disease. Nat Aging 1(8):634–650


Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A et al (2020) Apigenin as tumor suppressor in cancers: biotherapeutic activity, nanodelivery, and mechanisms with emphasis on pancreatic cancer. Front Chem. https://doi.org/10.3389/fchem.2020.00829


Azab AK, Muz B, Ghazarian R, Ou M, Luderer M et al (2016) Spotlight on ixazomib: potential in the treatment of multiple myeloma. Drug Des Dev Ther 10:217–226


Bhattarai KR, Chaudhary M, Kim H-R, Chae H-J (2020) Endoplasmic reticulum (ER) stress response failure in diseases. Trends Cell Biol 30(9):672–675


Cai SJ, Liu Y, Han S, Yang C (2019) Brusatol, an NRF2 inhibitor for future cancer therapeutic. Cell Biosci 9(1):45


Chaurasia M, Gupta S, Das A, Dwarakanath BS, Simonsen A et al (2019) Radiation induces EIF2AK3/PERK and ERN1/IRE1 mediated pro-survival autophagy. Autophagy 15(8):1391–1406


Chavez-Dominguez R, Perez-Medina M, Lopez-Gonzalez JS, Galicia-Velasco M, Aguilar-Cazares D (2020) The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity. Front Oncol. https://doi.org/10.3389/fonc.2020.578418


Chen M, Xie S (2018) Therapeutic targeting of cellular stress responses in cancer. Thorac Cancer 9(12):1575–1582


da Silva PFL, Schumacher B (2021) Principles of the molecular and cellular mechanisms of aging. J Invest Dermatol 141(4S):951–960


Darrigrand R, Pierson A, Rouillon M, Renko D, Boulpicante M et al (2021) Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens. Commun Biol 4(1):269


Desideri E, Ciccarone F, Ciriolo MR (2019) Targeting glutathione metabolism: partner in crime in anticancer therapy. Nutrients 11(8):1926


Ebstein F, Poli Harlowe MC, Studencka-Turski M, Krüger E (2019) Contribution of the unfolded protein response (UPR) to the pathogenesis of proteasome-associated autoinflammatory syndromes (PRAAS). Front Immunol. https://doi.org/10.3389/fimmu.2019.02756


Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A et al (2018) The continuum of aging and age-related diseases: common mechanisms but different rates. Front Med. https://doi.org/10.3389/fmed.2018.00061


Fu X, Cui J, Meng X, Jiang P, Zheng Q et al (2021) Endoplasmic reticulum stress, cell death and tumor: association between endoplasmic reticulum stress and the apoptosis pathway in tumors (review). Oncol Rep 45(3):801–808


Guo Z, Guozhang H, Wang H, Li Z, Liu N (2019) Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway. Biomed Pharmacother 116:108524


Huang M, Lu J-J, Ding J (2021) Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect 11(1):5–13


Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA et al (2019) Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother 112:108612


Jayaweera SPE, WanigasingheKanakanamge SP, Rajalingam D, Silva GN (2021) Carfilzomib: a promising proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma. Front Oncol. https://doi.org/10.3389/fonc.2021.740796


Jia P, Dai C, Cao P, Sun D, Ouyang R et al (2020) The role of reactive oxygen species in tumor treatment. RSC Adv 10(13):7740–7750


Kara M, Oztas E (2020) Endoplasmic reticulum stress-mediated cell death programmed cell death. IntechOpen, USA


Khan AQ, Rashid K, AlAmodi AA, Agha MV, Akhtar S et al (2021) Reactive oxygen species (ROS) in cancer pathogenesis and therapy: an update on the role of ROS in anticancer action of benzophenanthridine alkaloids. Biomed Pharmacother 143:112142


Kim SJ, Kim HS, Seo YR (2019) Understanding of ROS-inducing strategy in anticancer therapy. Oxid Med Cell Longev 2019:1–12


Kung F-P, Lim Y-P, Chao W-Y, Zhang Y-S, Yu H-I et al (2021) Piperlongumine, a potent anticancer phytotherapeutic, induces cell cycle arrest and apoptosis in vitro and in vivo through the ROS/Akt pathway in human thyroid cancer cells. Cancers 13(17):4266


Li Q, Wang Z, Xie Y, Hu H (2020) Antitumor activity and mechanism of costunolide and dehydrocostus lactone: two natural sesquiterpene lactones from the Asteraceae family. Biomed Pharmacother 125:109955


Liu Y, Shi Y (2020) Mitochondria as a target in cancer treatment. MedComm 1(2):129–139


Liu T, Zhang J, Li K, Deng L, Wang H (2020) Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front Pharmacol. https://doi.org/10.3389/fphar.2020.00408


Min F, Liu X, Li Y, Dong M, Qu Y et al (2021) Carnosic acid suppresses the development of oral squamous cell carcinoma via mitochondrial-mediated apoptosis. Front Oncol. https://doi.org/10.3389/fonc.2021.760861


Moghadam ZM, Henneke P, Kolter J (2021) From flies to men: ROS and the NADPH oxidase in phagocytes. Front Cell Dev Biol 9:618


Mulcahy Levy JM, Thorburn A (2020) Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ 27(3):843–857


Ong CP, Lee WL, Tang YQ, Yap WH (2019) Honokiol: a review of its anticancer potential and mechanisms. Cancers 12(1):48


Park JE, Miller Z, Jun Y, Lee W, Kim KB (2018) Next-generation proteasome inhibitors for cancer therapy. Transl Res 198:1–16


Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ (2019) Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med 51(12):1–13


Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192–203


Ren H, Zhai W, Lu X, Wang G (2021) The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson’s disease. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2021.691881


Sarvizadeh M, Hasanpour O, NaderiGhale-Noie Z, Mollazadeh S, Rezaei M et al (2021) Allicin and digestive system cancers: from chemical structure to its therapeutic opportunities. Front Oncol. https://doi.org/10.3389/fonc.2021.650256


Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L et al (2020) Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol. https://doi.org/10.3389/fphys.2020.00694


Sharifi-Rad J, Herrera-Bravo J, Salazar LA, Shaheen S, AbdulmajidAyatollahi S et al (2021) The therapeutic potential of Wogonin observed in preclinical studies. Evid Based Complement Alternat Med 2021:9935451


Song X, Tan L, Wang M, Ren C, Guo C et al (2021) Myricetin: a review of the most recent research. Biomed Pharmacother 134:111017


Talebi M, Talebi M, Farkhondeh T, Simal-Gandara J, Kopustinskiene DM et al (2021) Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin. Cancer Cell Int 21(1):214


Tian X, Zhang S, Zhou L, Seyhan AA, Hernandez Borrero L et al (2021) Targeting the integrated stress response in cancer therapy. Front Pharmacol. https://doi.org/10.3389/fphar.2021.747837


Verma K, Verma M, Chaphalkar A, Chakraborty K (2021) Recent advances in understanding the role of proteostasis. Fac Rev. https://doi.org/10.12703/r/10-72


Wu M-Y, Wang S-F, Cai C-Z, Tan J-Q, Li M et al (2017) Natural autophagy blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer cells to camptothecin-induced toxicity. Oncotarget 8(44):77673–77684


Wu S, Lu H, Bai Y (2019) Nrf2 in cancers: a double-edged sword. Cancer Med 8(5):2252–2267


Yang Y, Tian Z, Guo R, Ren F (2020) Nrf2 inhibitor, brusatol in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive cancers by inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 pathways. Oxid Med Cell Longev 2020:1–14


Yokoyama NN, Denmon AP, Uchio EM, Jordan M, Mercola D et al (2015) When anti-aging studies meet cancer chemoprevention: can anti-aging agent kill two birds with one blow? Curr Pharmacol Rep 1(6):420–433


Zhou Y, Shu F, Liang X, Chang H, Shi L et al (2014) Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway. PLoS ONE 9(2):e89021


Zhou Li, Gao W, Wang K, Huang Z, Zhang L et al (2019a) Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt-regulated autophagy. FASEB J 33(4):5520–5534


Zhou L, Tan J, Cao R, Xu J, Chen X et al (2019b) ATF6 regulates the development of chronic pancreatitis by inducing p53-mediated apoptosis. Cell Death Dis 10(9):662


Zhu M, Zhang P, Jiang M, Yu S, Wang L (2020) Myricetin induces apoptosis and autophagy by inhibiting PI3K/Akt/mTOR signalling in human colon cancer cells. BMC Complement Med Ther 20(1):209